The previous study has shown that oral FPP supplementation prevents the development of allergic rhinitis-like nasal symptoms without affecting systemic immune response, suggesting that FPP may act on the IgE-mast cell axis to exert its anti-allergic effect (Fujimura et al. 2018). This evidence concerns the gene IGHE and allergic rhinitis.